---
$id: https://graph.org.ai/products/commodity/51372202
$type: Product
source: UNSPSC
code: "51372202"
title: "Dextropropoxyphene or propoxyphene"
class: "51372200"
classTitle: "Controlled substance analgesic morpholines"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dextropropoxyphene or propoxyphene

**UNSPSC Code**: 51372202
**Class**: [Controlled substance analgesic morpholines](Controlled substance analgesic morpholines.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opiate with the molecular formula C22H29NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S2F83W92TK, chemically known as 4-dimethylamino-3-methyl-1,2-diphenyl-2-propoxybutane but generally known as dextropropoxyphene, which bears US NIH Compound Identifier 10100. European Medicines Agency schedules Dextropropoxyphene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07053MIG. The term DEXTROPROPOXYPHENE is an International Non-Proprietary Name. World Health Organization schedules dextropropoxyphene in its Anatomical Therapeutic Chemical (ATC) Classification. DEXTROPROPOXYPHENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Dextropropoxyphene or propoxyphene bears US NLM identifiers UMLS ID C0033493 and NCI Concept Code C61912. SMILES: O(C(C(CN(C)C)C)(CC1CCCCC1)C1CCCCC1)C(=O)CC.

